Skip to content
Get the Balanced News app for a better experience!
The Balanced News Logo
Analytics
The Balanced News Logo

Stay Balanced, Stay Informed

Menu
  • Browse News
  • Underreported Stories
  • Curated Feeds
  • Insights
  • Analytics
  • Our Writers
  • About Us
  • Download App
Learn
  • How It Works
  • Bias Detection
  • Lens Score
  • Source Bias Checker
  • Accountability
  • Custom Feeds
Newsroom
  • Writers & Analysts
  • About TBN
  • Editorial Standards
  • Corrections Policy
  • Our Partners
  • Insights
Socials
  • Youtube
  • Instagram
  • X
  • Facebook
News Categories
  • Trending
  • Politics
  • Sports
  • Business
  • Tech
  • Entertainment
  • Health
  • Science
  • Crime
  • Lifestyle
  • National
  • International
  • Good News
  • Crypto

Get Our App

Available for iOS and Android


LensFeedsInsightsAnalyticsTrendingGood NewsSportsPoliticsBusinessCrimeTechEntertainmentHealthNationalInternational

© 2026 The Balanced News. All rights reserved.

About UsEditorial StandardsCorrectionsHelp & SupportPrivacy PolicyTerms & Conditions
Evipatch Wearable Heart Monitor to Undergo Clinical Testing in Moscow

Categories

Categories

Related Coverage

Select a news story to see related coverage from other media outlets.

Related Coverage

Select a news story to see related coverage from other media outlets.

  1. Home
  2. /
  3. Technology

Evipatch Wearable Heart Monitor to Undergo Clinical Testing in Moscow

Analysed 16 Oct 2026·2 sources analysed·Moscow, Russia·Technology
Evipatch Wearable Heart Monitor to Undergo Clinical Testing in MoscowPreviousNext

Evymed has developed Evipatch, a wearable cardiac monitor that attaches to the chest with a waterproof adhesive patch and records electrocardiograms continuously for up to ten days. The device will be tested at the Scandinavian Health Center in Moscow as part of the Moscow Innovation Cluster's pilot testing programme announced at the Moscow Startup Summit. The trial aims to evaluate the device's usability for patients and healthcare professionals and its potential integration into medical practice. Successful results may lead to wider deployment.

Sentiment
50%
TBN's observations

First-hand measurement across 2 sources

We measured how 2 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is neutral (50/100). Lens Score 34/100.

Outlets measured: thetribune, news18. See how each one headlined and framed the same story in the source comparison below.

AI analysis of 2 sources · Published under editorial oversight by The Balanced News
Analysed 16 Oct 2026· How this analysis is produced· Editorial standards· Corrections

AI Analysis

Sentiment — Neutral (50/100)

Sentiment was consistent across outlets (50–50/100), indicating broadly factual reporting rather than editorialising.

Coverage timeline

news18 broke this story on 16 Oct, 12:47 pm. Other outlets followed.

16 Oct, 12:47 pm2 sources · 1 min16 Oct, 12:48 pm
  1. 1
AI analysis by the TBN Bias Engine · beat methodology byAshwin Alsi· Technology Editor· editorial standards byOjas Kale
← Previous
CEO Uses AI Agents to Reduce Weekly Family Management Time from Eight to Two Hours
Next →
Ai Smartphone Incorporates Customer Feedback to Improve Products and Services
news1816 Oct, 12:47 pm
New Wearable Heart Monitor to Be Tested in Moscow Clinic
  • 2
    thetribune16 Oct, 12:48 pm
    New Wearable Heart Monitor to Be Tested in Moscow Clinic - The Tribune
  • Who's involved

    Institutions and figures named across source coverage.

    Corporate
    Evymed

    Story context

    Category
    Tech
    Location
    Moscow, Russia
    Sources analysed
    2
    Last analysed
    16 Oct 2026
    Key entities
    Pilot experimentMoscowHealth professionalElectrocardiographyScandinaviaWaterproofingNew DelhiIndiaMaxim VlasovAtrial fibrillationAlgorithmChief executive officer